[Skip to Content]
[Skip to Content Landing]
Views 294
Citations 0
Research Letter
December 28, 2018

Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure

Author Affiliations
  • 1Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Australia, 4229
JAMA Intern Med. Published online December 28, 2018. doi:10.1001/jamainternmed.2018.6201

Expanding disease definitions are one driver of overdiagnosis and related overtreatment.1 In November 2017, new guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) expanded the definition of hypertension, extending the label to 46% of adults in the United States.2 The expanded definition was welcomed by some as an important public health initiative; however, other national and international groups, including the American Academy of Family Physicians, did not endorse the expanded definition amid concerns about potential harms.3 Concerns raised included potential overtreatment; intellectual conflicts of interest held by some of the panel members involved with the new ACC/AHA guideline, including members who were connected to a major trial that strongly influenced the guideline; and uncertainty regarding blood pressure measurement methods. A checklist-based analysis found that most people newly classified as hypertensive were unlikely to benefit, but instead could experience harms from being unnecessarily labeled as having hypertension, and some people could experience adverse effects from unnecessary medication.4 We investigated how the media covered the potential benefits and harms of the expanded definition of hypertension.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×